Shares of Mirum Pharmaceuticals, Inc. (MIRM) are climbing about 6 percent on Wednesday morning after the company announced the pricing of its offering of $600.0 million of convertible senior notes due 2032 in a private placement.
The company's shares are currently trading at $113.50 on the Nasdaq, up 6.19 percent. The stock opened at $108.00 and has climbed as high as $114.89 so far in today's session. Over the past year, it has traded in a range of $42.89 to $114.89.
For comments and feedback contact: editorial@rttnews.com
Business News
May 15, 2026 15:25 ET Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.